Boston Immune Technologies & Therapeutics
PrivateLast Round
Grant
Aug 16, 2024
Total Funding Raised
$20.4M
Company Overview
Boston Immune Technologies & Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in August 2024.
Boston Immune Technologies & Therapeutics is a biotechnology company that develops novel antagonist antibodies targeting TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Boston Immune Technologies & Therapeutics Comparables
Compare Boston Immune Technologies & Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salvina Therapeutics AG | 82% | |
| HiFiBiO Therapeutics | 80% | |
| INmune Bio Inc | 78% |
For institutional investors. Book with your work email.
Boston Immune Technologies & Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 16, 2024 | ||||
| Grant | Sep 1, 2021 | ||||
| Series A | Mar 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Boston Immune Technologies & Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Hatteras Venture Partners | Series A |
| Evli Growth Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 289% MoM, reaching 1.2K.
- Jan 8, 2026
Monthly visitors grew 2298% MoM, from 43 to 1K.
For institutional investors. Book with your work email.
Boston Immune Technologies & Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Boston Immune Technologies & Therapeutics's valuation, stock price, and market status.
Is Boston Immune Technologies & Therapeutics a public or private company?
Boston Immune Technologies & Therapeutics is a private company.
What is the current stock price of Boston Immune Technologies & Therapeutics?
Boston Immune Technologies & Therapeutics is a private company, so its shares have no public market price. Caplight tracks Boston Immune Technologies & Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Boston Immune Technologies & Therapeutics worth (valuation)?
Valuation information for Boston Immune Technologies & Therapeutics is not publicly available.
Can I buy Boston Immune Technologies & Therapeutics stock?
Boston Immune Technologies & Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Boston Immune Technologies & Therapeutics's last funding round?
Boston Immune Technologies & Therapeutics's most recent funding round was Grant on August 16, 2024.
Who are the main investors in Boston Immune Technologies & Therapeutics?
Key investors in Boston Immune Technologies & Therapeutics include National Cancer Institute, Hatteras Venture Partners, Evli Growth Partners.
Will Boston Immune Technologies & Therapeutics IPO soon?
No public IPO plans have been announced for Boston Immune Technologies & Therapeutics.
How can I track Boston Immune Technologies & Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Boston Immune Technologies & Therapeutics's shares on secondary markets.